XT LABS TXT 400 (CYPIONATE-PROPIONATE) 400 MG / 10 ML

XT Labs TXT 400 (Testosterone Cypionate / Testosterone Propionate Blend) | NexorinPharma

XT Labs TXT 400 is an injectable testosterone blend containing 400mg of combined Testosterone Cypionate and Testosterone Propionate per milliliter in a 10ml vial. At NexorinPharma, we carry XT Labs TXT 400 as part of our injectable testosterone inventory for customers in markets where testosterone preparations are legally available.

TXT 400 is a dual-ester testosterone preparation. It combines the long-acting cypionate ester with the short-acting propionate ester in a single injectable formulation. This combination produces a staggered release profile. The propionate ester delivers faster-onset testosterone activity while the cypionate ester sustains elevated plasma concentrations over a longer period following each injection.

Like all testosterone-based anabolic-androgenic steroids, XT Labs TXT 400 carries significant health and legal considerations. This page covers what TXT 400 is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage steroid use. It does not provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

Website: nexorinpharma.com Product Name: XT Labs TXT 400 Manufacturer: XT Labs Active Compounds: Testosterone Cypionate, Testosterone Propionate Drug Class: Anabolic-androgenic steroid, testosterone blend Total Concentration: 400mg per milliliter Vial Size: 10ml Total Content: 4000mg per vial Presentation: Injectable solution Form: Oil-based injectable Cypionate Ester Half-Life: Approximately 7 to 12 days Propionate Ester Half-Life: Approximately 2 to 3 days Route of Administration: Intramuscular injection Anabolic Rating: 100 relative to testosterone baseline Androgenic Rating: 100 relative to testosterone baseline Aromatization: Yes Legal Status: Schedule III controlled substance in the United States. Prescription required. Legal status varies by country.

About XT Labs

XT Labs is a Mexican anabolic steroid manufacturer with a strong presence in Latin American performance markets and broader international recognition in bodybuilding and performance communities. The brand produces a comprehensive range of injectable and oral anabolic steroid products for markets where such compounds are legally available.

Like all manufacturers operating outside regulated pharmaceutical channels, XT Labs does not carry the manufacturing oversight, regulatory scrutiny, or clinical trial documentation of pharmaceutical grade prescription products. Consequently, quality, purity, and concentration accuracy are less verifiable than with regulated products. Within the non-prescription market, however, XT Labs carries consistent brand recognition particularly across Latin American and international performance communities.

What Is TXT 400

TXT 400 is a dual-ester testosterone blend. It combines two testosterone esters with different release rates in a single injectable preparation. The active compound in both cases is testosterone. The difference between the two components is the ester attached to the base testosterone molecule, which determines how quickly each component releases into the bloodstream following injection.

Testosterone is the primary male sex hormone. The body produces it naturally in the testes. It drives male secondary sexual characteristics, muscle mass, bone density, red blood cell production, reproductive function, and numerous other physiological processes throughout the body.

The 400mg per milliliter total concentration of TXT 400 is notably higher than most single-ester testosterone preparations in non-prescription markets, which are commonly produced at 200mg to 250mg per milliliter. This higher concentration per milliliter is a relevant consideration for anyone researching this specific product.

How the Dual-Ester Blend Works

TXT 400 produces its pharmacological effects through testosterone released from both ester components simultaneously following injection. Each ester contributes a distinct release rate and duration profile to the overall preparation.

Testosterone Propionate Component

The propionate ester is a short-acting testosterone ester with a half-life of approximately 2 to 3 days. Following injection, the propionate component releases testosterone relatively quickly into the bloodstream. As a result, the propionate component contributes faster-onset testosterone activity to the TXT 400 blend profile. This faster onset distinguishes TXT 400 from pure long-acting single-ester preparations like Testosterone Cypionate alone.

Testosterone Cypionate Component

The cypionate ester is a long-acting testosterone ester with a half-life of approximately 7 to 12 days. Following injection, the cypionate component releases testosterone gradually over a significantly longer period than the propionate component. Consequently, the cypionate component sustains elevated testosterone plasma concentrations well beyond the initial faster-onset activity produced by the propionate component. This sustained release profile is the primary contributor to the extended activity window of TXT 400.

Combined Staggered Release Profile

The combination of fast-onset propionate activity and sustained cypionate activity produces a staggered release profile from a single injection. The propionate component drives early testosterone elevation following injection. The cypionate component then sustains that elevation over an extended period. As a result, TXT 400 produces a broader and more sustained testosterone activity window than either ester would produce individually at the same total dose.

How Testosterone Works

Once released from their respective esters, both testosterone components in TXT 400 become free testosterone and function identically in the body. Free testosterone binds to androgen receptors throughout the body, driving the same physiological effects regardless of which ester delivered it.

Androgen Receptor Binding

Free testosterone binds to androgen receptors throughout the body. This binding drives effects on muscle protein synthesis, nitrogen retention, bone density, red blood cell production, and fat metabolism. As a result, androgen receptor activation is the primary mechanism through which TXT 400 produces its physiological effects.

Estrogen Conversion

Testosterone converts to estrogen through the aromatase enzyme, producing estradiol as a byproduct of testosterone metabolism. Some estrogen is normal and necessary in the male body. However, excess estrogen conversion produces side effects including water retention, gynecomastia, and mood changes. Therefore, managing estrogen conversion is a primary consideration with any testosterone-based compound. The higher 400mg per milliliter concentration of TXT 400 makes estrogen management particularly relevant compared to lower-concentration preparations.

DHT Conversion

Testosterone also converts to Dihydrotestosterone through the 5-alpha reductase enzyme. DHT is a more potent androgen than testosterone in certain tissues, particularly skin and hair follicles. Consequently, DHT conversion contributes to androgenic side effects including hair loss and acne in susceptible individuals.

Nitrogen Retention

Testosterone promotes positive nitrogen balance in muscle tissue. The body retains more nitrogen than it excretes. As a result, this supports an anabolic environment that favors muscle repair and growth following training.

Red Blood Cell Production

Testosterone stimulates erythropoietin production in the kidneys, increasing red blood cell production and raising hematocrit levels. Higher hematocrit improves oxygen-carrying capacity in the blood. However, it also raises cardiovascular risk if levels become excessive, making hematocrit monitoring a relevant health consideration with testosterone use.

IGF-1 Stimulation

Testosterone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism contributes to the recovery-related observations consistently reported in performance community discussions about testosterone use.

About the 400mg Concentration and 10ml Vial

The 400mg per milliliter concentration of TXT 400 is significantly higher than most single-ester testosterone preparations available in non-prescription markets. Understanding this distinction is important context for anyone researching this specific product.

Higher Concentration Considerations

Standard non-prescription market Testosterone Cypionate and Testosterone Enanthate preparations are commonly produced at 250mg per milliliter. The 400mg per milliliter concentration of TXT 400 consequently represents a 60 percent higher concentration per milliliter than these standard formats. Higher concentration per milliliter carries relevant injection volume and tolerability considerations. Higher-concentration oil-based injectables are commonly associated with greater injection site discomfort than lower-concentration preparations.

10ml Vial Format

The 10ml vial format of TXT 400 contains a total of 4000mg of combined testosterone esters. This multi-dose vial format provides a larger total supply than single-dose or smaller-volume vials. Proper sterile practices are consequently essential when drawing from a multi-dose vial to avoid contamination over multiple uses.

Non-Prescription Market Context

XT Labs produces TXT 400 for markets where testosterone preparations are legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade prescription products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.

TXT 400 Versus Other Testosterone Preparations

Versus Single-Ester Testosterone Cypionate

Single-ester Testosterone Cypionate preparations produce a single consistent release profile driven exclusively by the cypionate ester’s half-life of approximately 7 to 12 days. TXT 400, on the other hand, adds the propionate component’s faster-onset activity to the cypionate component’s sustained release. As a result, TXT 400 produces faster initial testosterone elevation following injection compared to single-ester cypionate preparations alone.

Versus Single-Ester Testosterone Propionate

Single-ester Testosterone Propionate preparations produce a fast-onset but short-duration release profile driven exclusively by the propionate ester’s half-life of approximately 2 to 3 days. TXT 400 extends this duration significantly through the cypionate component’s sustained release. Consequently, TXT 400 requires less frequent injection than pure Testosterone Propionate to maintain stable plasma concentrations.

Versus Sustanon

Sustanon is a multi-ester testosterone blend combining four testosterone esters: propionate, phenylpropionate, isocaproate, and decanoate. It consequently produces a more complex multi-phase release profile than TXT 400’s dual-ester combination. TXT 400’s two-ester profile produces a simpler and more predictable concentration curve compared to Sustanon’s four-ester blend. In addition, TXT 400’s higher total concentration of 400mg per milliliter exceeds Sustanon’s standard 250mg per milliliter concentration.

Versus Testosterone Enanthate

Testosterone Enanthate is a single long-acting ester preparation with a half-life of approximately 7 to 10 days. Like single-ester Testosterone Cypionate, it produces a single consistent release profile without the faster-onset initial activity contributed by TXT 400’s propionate component. TXT 400 consequently produces a broader activity window than Testosterone Enanthate alone through its dual-ester staggered release mechanism.

Clinical Background

Testosterone Cypionate carries FDA approval for testosterone replacement therapy in men with hypogonadism, treatment of delayed puberty in males, and palliative treatment in certain cases of metastatic breast cancer in women. Testosterone Propionate carries a documented clinical history of use in testosterone replacement therapy across various markets, though it is less commonly used in current clinical practice than longer-acting ester preparations due to its more frequent injection requirements.

The TXT 400 dual-ester blend format does not directly correspond to any specific FDA-approved pharmaceutical presentation. Standard clinical testosterone preparations use single esters at established concentrations. The 400mg per milliliter dual-ester blend is a non-prescription market format produced outside of standard clinical dosing frameworks.

Side Effects and Health Risks

XT Labs TXT 400 carries a well-documented side effect profile consistent with testosterone-based anabolic-androgenic steroids. The higher 400mg per milliliter concentration and dual-ester profile introduce additional considerations beyond those of standard single-ester clinical preparations.

Estrogenic Effects

Testosterone converts to estrogen through the aromatase enzyme. Elevated estrogen levels produce water retention, gynecomastia, and mood changes. As a result, aromatase inhibitors are commonly used to manage estrogen conversion in anyone using testosterone-based compounds. The higher concentration of TXT 400 makes estrogenic side effect management particularly relevant.

Androgenic Effects

Androgenic side effects include accelerated hair loss in genetically predisposed individuals and acne on the face and back. In women, virilization risks including voice deepening and changes in body hair distribution are serious considerations with any testosterone preparation.

Hormonal Suppression

Testosterone Cypionate and Testosterone Propionate both suppress the body’s natural testosterone production by signaling the HPG axis to reduce endogenous output. Post-use hormonal disruption can persist for months. In some cases, it results in long-term or permanent hypogonadism requiring ongoing medical treatment.

Cardiovascular Effects

Testosterone use reduces HDL cholesterol and raises LDL cholesterol. In addition, elevated hematocrit from increased red blood cell production raises blood viscosity and cardiovascular risk. Long-term use is also associated with left ventricular hypertrophy. Therefore, regular cardiovascular monitoring is important for anyone using testosterone-based compounds.

Injection Site Reactions

Higher-concentration oil-based injectables carry greater injection site reaction risks than lower-concentration preparations. Pain, swelling, and in rare cases infection are relevant considerations with TXT 400’s 400mg per milliliter concentration. Proper injection technique and sterile multi-dose vial practices are therefore essential.

Psychological Effects

Elevated testosterone levels carry documented associations with mood changes and irritability. In some cases, more significant psychological effects occur at higher plasma concentrations. These considerations are relevant at the higher concentrations associated with TXT 400’s 400mg per milliliter formulation.

Legal and Regulatory Status

Testosterone and its esters carry FDA approval for specific clinical indications. Outside of those indications, however, they carry Schedule III controlled substance status in the United States under the Controlled Substances Act. Possession without a valid prescription is a federal offense.

In the United Kingdom, testosterone esters fall under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans testosterone and all its esters in competitive sports outside of documented therapeutic use exemptions. As a result, they appear on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of testosterone preparations in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is XT Labs TXT 400 Available at NexorinPharma

Yes. NexorinPharma carries XT Labs TXT 400 for customers in markets where testosterone preparations are legally available. Visit nexorinpharma.com to check current availability and pricing.

What Are the Half-Lives of the Two Ester Components

The propionate ester produces a half-life of approximately 2 to 3 days. The cypionate ester produces a half-life of approximately 7 to 12 days. Together, these two half-lives produce a staggered release profile with faster initial onset from the propionate component and sustained elevation from the cypionate component.

Does TXT 400 Aromatize

Yes. Both testosterone components in TXT 400 convert to estrogen through the aromatase enzyme. Managing estrogen conversion is therefore a primary health consideration for anyone using this preparation, particularly given its higher 400mg per milliliter concentration.

How Does TXT 400 Differ From Single-Ester Testosterone Preparations

TXT 400 combines two esters with different release rates in a single preparation. This produces a staggered release profile with faster initial testosterone elevation from the propionate component and sustained plasma concentration maintenance from the cypionate component. Single-ester preparations produce a single consistent release profile from one ester alone.

What Are the Most Serious Health Risks

Cardiovascular effects including lipid dysregulation, elevated hematocrit, and potential cardiac remodeling are the most clinically significant concerns. In addition, hormonal suppression, estrogenic effects, androgenic effects, injection site reactions from the higher concentration, and psychological impacts complete the primary risk profile. Medical supervision is therefore essential for anyone using testosterone-based compounds.

Is TXT 400 Legal to Purchase

Testosterone esters carry Schedule III controlled substance status in the United States and require a valid prescription. Legal status varies by jurisdiction. You are responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing XT Labs TXT 400

Testosterone Cypionate and Testosterone Propionate individually carry established clinical research bases and documented pharmacological profiles. The dual-ester blend format and higher 400mg per milliliter concentration of TXT 400, however, represent a non-prescription market presentation produced outside of standard clinical dosing frameworks. As a result, the side effect and tolerability considerations at this specific concentration exceed those documented in standard clinical testosterone research.

The XT Labs non-prescription format does not carry the manufacturing oversight of pharmaceutical grade products. Furthermore, the higher 400mg per milliliter concentration introduces injection site tolerability and estrogen management considerations beyond those of standard lower-concentration single-ester preparations.

Testosterone carries documented cardiovascular, hormonal, estrogenic, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Therefore, consulting a licensed medical professional is the appropriate starting point for anyone with health concerns related to testosterone use.

For customers in markets where testosterone preparations are legally available, visit nexorinpharma.com to check current XT Labs TXT 400 availability, pricing, and stock levels.